UC280

ケトコナゾール

≥99% (HPLC), Cytochrome P450c17 inhibitor, solid

• 別名: (±)-cis-1-アセチル-4-(4-[(2-[2,4-ジクロロフェニル]-2-[1H-イミダゾール-1-イルメチル]-1,3-ジオキソラン-4-イル)-メトキシ]フェニル)ピペラジン
• 実験式（ヒル表記法）: C₂₆H₂₈Cl₂N₄O₄
• CAS番号: 65277-42-1
• 分子量: 531.43
• NACRES: NA.77
• PubChem Substance ID: 24724652
• UNSPSC Code: 12161501
• EC Number: 265-667-4
• MDL number: MFCD00058579
• Assay: ≥99% (HPLC)
• Form: solid

特性

• 製品名: ケトコナゾール,
• assay: ≥99% (HPLC)
• form: solid
• color: white to light yellow
• solubility: DMSO: soluble
• antibiotic activity spectrum: fungi, yeast
• mode of action: enzyme | inhibits
• originator: Johnson & Johnson
• storage temp.: 2-8°C
• SMILES string: CC(=O)N1CCN(CC1)c2ccc(OC[C@H]3CO[C@@](Cn4ccnc4)(O3)c5ccc(Cl)cc5Cl)cc2
• InChI: 1S/C26H28Cl2N4O4/c1-19(33)31-10-12-32(13-11-31)21-3-5-22(6-4-21)34-15-23-16-35-26(36-23,17-30-9-8-29-18-30)24-7-2-20(27)14-25(24)28/h2-9,14,18,23H,10-13,15-17H2,1H3/t23-,26-/m0/s1
• InChI key: XMAYWYJOQHXEEK-OZXSUGGESA-N
• Gene Information: human ... ABCB1(5243), CYP11B1(1584), CYP11B2(1585), CYP17A1(1586), CYP19A1(1588), CYP1A2(1544), CYP24A1(1591), CYP26A1(1592), CYP3A4(1576), CYP51A1(1595), KCNH1(3756) ; mouse ... Abcb1a(18671), Abcb1b(18669) ; rat ... Alox5(25290), Cyp17a1(25146), Cyp51(25427), Cyp7a1(25428) ;

詳細

Application

CYP3A4インヒビタ-

Ketoconazole has been used as a cytochrome P450 (CYP) inhibitor to study its functions in embryonic testes of rats. Ketoconazole has also been used for the screening of antimicrobial agents against nonreplicating M. tuberculosis. Furthermore, studies have used ketoconazole for antifungal susceptibility testing and also as a standard antifungal agent.

Biochem/physiol Actions

抗真菌薬

Ketoconazole is an imidazole derivative. It plays an important role in inhibiting the conversion of lanosterol to ergosterol in the cell wall of fungi. Ketoconazole has therapeutic effects against dermatophytosis, superficial candidiasis, and paracoccidioidomycosis.

Features and Benefits

This compound is a featured product for ADME Tox research. Click here to discover more featured ADME Tox products. Learn more about bioactive small molecules for other areas of research at sigma.com/discover-bsm.

This compound was developed by Johnson & Johnson. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.

Packaging

底の開いたガラス瓶内容物は内部に挿入され接着された円錐部に入っています。

Preparation Note

Ketoconazole is soluble in DMSO.

安全性情報

• ピクトグラム: GHS06,GHS08,GHS09
• 注意喚起語: Danger
• ハザードコード: H301,H360F,H373,H410
• 注意事項: P202 - P260 - P264 - P273 - P280 - P301 + P310
• Hazard Classifications: Acute Tox. 3 Oral - Aquatic Acute 1 - Aquatic Chronic 1 - Repr. 1B - STOT RE 2
• 保管分類: 6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects
• 一体何が起きているの？: WGK 3
• 引火点 (F): Not applicable
• 引火点（°C）: Not applicable
• PPE（個人用保護具）: Eyeshields, Faceshields, Gloves, type P2 (EN 143) respirator cartridges